12:00 AM
 | 
Jul 23, 2015
 |  BC Innovations  |  Distillery Therapeutics

Therapeutics: CMV CC chemokine receptor (US28)

Infectious disease

INDICATION: Cytomegalovirus (CMV)

In vitro and mouse studies identified a bacterial toxin-based inhibitor of US28 that could help treat human cytomegalovirus (HCMV) infection. Chemical synthesis and in vitro testing of chemokine-toxin fusion proteins identified a compound consisting of chemokine CX3C motif...

Read the full 187 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Innovations

Article Purchase

$35 USD
More Info >